BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23525237)

  • 1. Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.
    Park JH; Bae JY; Park HH
    Int J Mol Med; 2013 May; 31(5):1280-7. PubMed ID: 23525237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the assembly of CARMA1 and BCL10.
    Li S; Yang X; Shao J; Shen Y
    PLoS One; 2012; 7(8):e42775. PubMed ID: 22880103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel disulfide bond-mediated dimerization of the CARD domain was revealed by the crystal structure of CARMA1 CARD.
    Jang TH; Park JH; Park HH
    PLoS One; 2013; 8(11):e79778. PubMed ID: 24224005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
    David L; Li Y; Ma J; Garner E; Zhang X; Wu H
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
    Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
    Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reconstitution of interactions in the CARD9 signalosome.
    Park JH; Choi JY; Mustafa MF; Park HH
    Mol Med Rep; 2017 Oct; 16(4):3910-3916. PubMed ID: 28765954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary X-ray crystallographic studies of the CARD domain of human CARMA1.
    Park JH; Park HH
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Apr; 69(Pt 4):435-7. PubMed ID: 23545653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
    Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
    J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
    Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
    Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
    Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
    EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
    Edin S; Oruganti SR; Grundström C; Grundström T
    Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.
    Wegener E; Oeckinghaus A; Papadopoulou N; Lavitas L; Schmidt-Supprian M; Ferch U; Mak TW; Ruland J; Heissmeyer V; Krappmann D
    Mol Cell; 2006 Jul; 23(1):13-23. PubMed ID: 16818229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
    Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
    Front Immunol; 2018; 9():2695. PubMed ID: 30515170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells.
    Rigo M; Chentouf M; Pèlegrin A; Chardès T
    Cell Immunol; 2011; 270(1):40-6. PubMed ID: 21489413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.